1. Long non-coding RNA XLOC_008466 acts as an oncogenic molecular in cervical cancer tumorigenesis
    Fang Guo et al, 2018, Biomedicine & Pharmacotherapy CrossRef
  2. Streptomyces sp metabolite(s) promotes Bax mediated intrinsic apoptosis and autophagy involving inhibition of mTOR pathway in cervical cancer cell lines
    Vipin Mohan Dan et al, 2018, Sci Rep CrossRef
  3. Additive cytotoxic effects of radiation and mTOR inhibitors in a cervical cancer cell line
    Daniele Xavier Assad et al, 2018, Pathology - Research and Practice CrossRef
  4. Potential of the dual mTOR kinase inhibitor AZD2014 to overcome paclitaxel resistance in anaplastic thyroid carcinoma
    Zorica Milošević et al, 2018, Cell Oncol. CrossRef
  5. Impact of PI3K-AKT-mTOR Signaling Pathway Upregulation on the Prognosis of Penile Squamous Cell Carcinoma: Results from a Tissue Microarray Study and Review of the Literature
    Mounsif Azizi et al, 2018, Clinical Genitourinary Cancer CrossRef
  6. The Next Generation Scientist program: capacity-building for future scientific leaders in low- and middle-income countries
    Goonaseelan Pillai et al, 2018, BMC Med Educ CrossRef

  7. circRNA MYLK Accelerates Cervical Cancer via Up-Regulation of RHEB and Activation of mTOR Signaling


    Rui Chen et al, 2020, CMAR CrossRef
  8. Abemaciclib sensitizes HPV‐negative cervical cancer to chemotherapy via specifically suppressing CDK4/6‐Rb‐E2F and mTOR pathways
    Yuan Liu et al, 2020, Fundam Clin Pharmacol CrossRef
  9. Vulvar Squamous Cell Carcinoma: Comprehensive Genomic Profiling of HPV+ Versus HPV– Forms Reveals Distinct Sets of Potentially Actionable Molecular Targets
    Erik A. Williams et al, 2020, JCO Precision Oncology CrossRef
  10. Discovery of 3-(Benzofuran-2-ylmethyl)-1H-Indole Derivatives as Potential Autophagy Inducers in Cervical Cancer Cells
    Shaziyaparveen K. Siddiqui et al, 2020, Bioorganic & Medicinal Chemistry Letters CrossRef
  11. UBE2C Drives Human Cervical Cancer Progression and Is Positively Modulated by mTOR
    An-Jen Chiang et al, 2020, Biomolecules CrossRef
  12. mTOR inhibitors from a diagnostic perspective: radiolabeling of everolimus and its nanoformulation, in vitro incorporation assays against cervix and ovarian cancer cells
    Ahmet Bilgi et al, 2021, J Radioanal Nucl Chem CrossRef
  13. PIK3CA Mutations and Their Impact on Survival Outcomes of Patients with Cervical Cancer: A Systematic Review
    Vasilios Pergialiotis et al, 2020, Acta Cytologica CrossRef
  14. Changes in T lymphocyte subsets in peripheral blood of patients with middle-advanced cervical cancer before and after nimotuzumab combined with concurrent chemoradiotherapy
    Man Ao et al, 2023, Journal of Obstetrics and Gynaecology CrossRef
  15. Molecular mechanisms augmenting resistance to current therapies in clinics among cervical cancer patients
    Soumik Das et al, 2023, Med Oncol CrossRef
  16. Interactions of EGFR/PTEN/mTOR-Pathway Activation and Estrogen Receptor Expression in Cervical Cancer
    Thomas Bartl et al, 2023, JPM CrossRef
  17. The Mutational and Microenvironmental Landscape of Cutaneous Squamous Cell Carcinoma: A Review
    Tara M. Hosseini et al, 2024, Cancers CrossRef